Voice Analysis for Monitoring Patients With Heart Failure

Last updated: August 19, 2024
Sponsor: Noah Labs
Overall Status: Active - Recruiting

Phase

N/A

Condition

Chest Pain

Heart Failure

Hyponatremia

Treatment

N/A

Clinical Study ID

NCT06566911
23-011322
  • Ages > 18
  • All Genders

Study Summary

This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Clinically diagnosed with Acutely Decompensated Heart Failure.

  • At least 18 years of age.

Exclusion

Exclusion criteria:

  • Disabling mental diseases (e.g., Alzheimer's disease)

  • Clinically diagnosed chronic obstructive pulmonary disease (COPD)

  • Treatment in ICU or IMU

  • Dialysis treatment

  • Previous operations on organs involved in generation of voice (vocal tract, vocalfolds, etc.)

  • Neurodegenerative diseases

  • Pregnancy

  • Inability to provide consent

Study Design

Total Participants: 70
Study Start date:
January 24, 2024
Estimated Completion Date:
September 30, 2024

Connect with a study center

  • Deutsches Herzzentrum der Charité

    Berlin, 13353
    Germany

    Completed

  • Mayo Clinic

    Rochester, Minnesota 55902
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.